In human breast cancer, it has been shown that necrosis can occur through finely tuned regulation of a series of pro-necrotic genes including MLKL, RIPK1, RIPK3, PGAM5, and DFNA520. The gene discussed is RIPK1; the disease is breast carcinoma.